{
  "actions": [
    {
      "acted_at": "2006-03-09T13:51:00-05:00", 
      "references": [
        {
          "reference": "CR H834-835", 
          "type": "consideration"
        }, 
        {
          "reference": "CR H834", 
          "type": "text"
        }
      ], 
      "text": "Amendment (A011) offered by Mr. Lynch.", 
      "type": "action"
    }, 
    {
      "acted_at": "2006-03-09T14:02:00-05:00", 
      "how": "by voice vote", 
      "references": [], 
      "result": "pass", 
      "text": "On agreeing to the Lynch amendment (A011) Agreed to by voice vote.", 
      "type": "vote", 
      "vote_type": "vote", 
      "where": "h"
    }
  ], 
  "amendment_id": "hamdt696-109", 
  "amendment_type": "hamdt", 
  "amends_amendment": null, 
  "amends_bill": {
    "bill_id": "hr2829-109", 
    "bill_type": "hr", 
    "congress": 109, 
    "number": 2829
  }, 
  "amends_treaty": null, 
  "chamber": "h", 
  "congress": "109", 
  "description": "Amendment requires the Director of the Office of National Drug Control Policy to request the Institute of Medicine of the National Academy of Sciences to conduct a study to examine certain aspects of iatrogenic addiction, which is associated with prescription drugs like OxyContin.", 
  "house_number": 11, 
  "introduced_at": "2006-03-09", 
  "number": 696, 
  "purpose": "An amendment numbered 11 printed in House Report 109-387 to direct the ONDCP to request the Institute of Medicine of the National Academy of Sciences to enter into an agreement under which the Institute agrees to conduct a study on iatrogenic addiction associated with oxycodone hydrochloride controlled-release tablets and directs the ONDCP to report to Congress on the study.", 
  "sponsor": {
    "district": "9", 
    "name": "Lynch, Stephen F.", 
    "state": "MA", 
    "thomas_id": "01686", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "pass", 
  "status_at": "2006-03-09T14:02:00-05:00", 
  "updated_at": "2013-07-17T08:16:18-04:00"
}